Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial.
Cavalieri S, Bruno E, Serafini MS, Lenoci D, Canevari S, Lopez-Perez L, Hernandez L, Mariani L, Miceli R, Gavazzi C, Pasanisi P, Rosso E, Cordero F, Bossi P, Golusinski W, Dietz A, Strojan P, Fuereder T, De Cecco L, Licitra L. Cavalieri S, et al. Front Oncol. 2024 Jan 4;13:1321174. doi: 10.3389/fonc.2023.1321174. eCollection 2023. Front Oncol. 2024. PMID: 38239654 Free PMC article.
Immunotherapy for recurrent/metastatic head and neck cancer.
Alfieri S, Cavalieri S, Licitra L. Alfieri S, et al. Among authors: cavalieri s. Curr Opin Otolaryngol Head Neck Surg. 2018 Apr;26(2):152-156. doi: 10.1097/MOO.0000000000000448. Curr Opin Otolaryngol Head Neck Surg. 2018. PMID: 29432222 Review.
Lenvatinib-induced renal failure: two first-time case reports and review of literature.
Cavalieri S, Cosmai L, Genderini A, Nebuloni M, Tosoni A, Favales F, Pistillo P, Bergamini C, Bossi P, Licitra L, Locati LD, Alfieri S. Cavalieri S, et al. Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):379-385. doi: 10.1080/17425255.2018.1461839. Epub 2018 Apr 13. Expert Opin Drug Metab Toxicol. 2018. PMID: 29617171 Free article. Review.
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
Cavalieri S, Perrone F, Miceli R, Ascierto PA, Locati LD, Bergamini C, Granata R, Alfieri S, Resteghini C, Galbiati D, Busico A, Paielli N, Patuzzo R, Maurichi A, Gallino G, Ruggeri R, Mariani L, Palla M, Licitra L, Bossi P. Cavalieri S, et al. Eur J Cancer. 2018 Jul;97:7-15. doi: 10.1016/j.ejca.2018.04.004. Epub 2018 May 4. Eur J Cancer. 2018. PMID: 29734047 Clinical Trial.
Fatigue, a major still underestimated issue.
Ripamonti CI, Antonuzzo A, Bossi P, Cavalieri S, Roila F, Fatigoni S. Ripamonti CI, et al. Among authors: cavalieri s. Curr Opin Oncol. 2018 Jul;30(4):219-225. doi: 10.1097/CCO.0000000000000451. Curr Opin Oncol. 2018. PMID: 29877886 Review.
290 results